This report was recently updated on September 21 2023 with the latest and most recent
market numbers
Global In-vitro Diagnostics (IVD) Quality Control Market Size, Trends & Analysis - Forecasts to 2026 By Type (Quality Control, Quality Assurance Services, Data Management Solutions), By End-Use (Hospitals, Laboratories, Home-care, Others), By Application (Immunochemistry, Chemical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Others), By Region (North America, Europe, Asia Pacific, CSA, MEA); End User Landscape, Vendor Landscape, and Company Market Share Analysis & Competitor Analysis
In-vitro Diagnostics (IVD) Quality Control Market: Insights
The global in-vitro diagnostics (IVD) quality control market is expected to generate revenue amounting to USD 961 million in 2020 and is projected to reach USD 1.24 billion by 2026, growing at a CAGR of 4.1% over the forecast period. The rising number of accredited clinical laboratories worldwide due to increasing incidences of chronic diseases such as cardiovascular disease, cancer, and other respiratory diseases is expected to propel the market growth during the forecast period. According to the data published by the World Health Organization Report 2019, respiratory diseases are the leading cause of death globally, which accounts for around 4.0 million deaths every year. The in-vitro diagnostic (IVD) industry is experiencing rapid technological developments. Laboratories are aiming to differentiate themselves by providing advanced tests, such as medication analysis, expanded lipid profile, and clinical product tracking. Growth in the geriatric population along with growing air pollution resulting in respiratory diseases across various regions including North America, Europe, Asia Pacific, and Central & South America is further projected to propel the market growth for in vitro diagnostics (IVD) quality control. However, the high cost of IVD control services is likely to hamper the market growth over the coming years.
In-vitro Diagnostics (IVD) Quality Control Market Size: By Segmentation
The global in vitro diagnostics (IVD) quality control market is segmented on the basis of type into quality control, quality assurance services, and data management solutions. The quality control segment is expected to hold the largest market share in the global in vitro diagnostics (IVD) quality control market during the forecast period. Quality Control refers to techniques for monitoring work processes, detecting problems and requiring changes prior to the implementation of products or services. Growing need to ensure high-quality clinical test results is expected to propel the market growth. Quality control in the laboratory focuses on ensuring that the results delivered to the patient are accurate.
On the basis of application, the market is segmented into immunochemistry, hematology, clinical chemistry, molecular diagnostics, coagulation, and microbiology, among others. The immunochemistry segment is expected to hold the largest market share in the global in vitro diagnostics (IVD) quality control market during the forecast period. Main applications in immunochemistry include the detection in infectious microorganisms such as influenza, bacteria, and fungi by detecting the expression of their toxins and coat antigens. Growing usage of multi-analyte controls to conduct immunoassay experiments in laboratories are some of the major factors driving the market growth for in vitro diagnostics (IVD) quality control market. Furthermore, the molecular diagnostics segment is projected to grow at a high CAGR during the forecast period.
On the basis of end-use, the market is segmented into hospitals, laboratories, and home-care, among others. The hospital segment is expected to hold the largest market share during the forecast period. Increasing prevalence of respiratory chronic diseases, a growing number of admissions, and improving the reliability of healthcare practitioners on clinical diagnoses and the option of treatment alternatives are expected to propel the market growth during the forecast period. Moreover, the growing healthcare expenditure along with the growing number of hospitals in the developing nations are driving the market growth for the hospital segment.
In-vitro Diagnostics (IVD) Quality Control Market Size: By Region
Based on region, the market of in-vitro diagnostics (IVD) quality control is segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. The North America region is expected to dominate the market during the forecast period. A growing number of IVD tests and increasing use of third-party quality controls among clinical laboratories are some of the factors driving the market growth. Moreover, an advanced healthcare system and the growing prevalence of chronic diseases are driving the market growth in the region. Presence of prominent players such as Abbott Laboratories, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., Quidel Corp., Becton, Dickinson, and Company (BD), bioMerieux, Inc., and Sysmex Corp, among others is driving the market growth in the region.
The Asia Pacific region is expected to grow at a high CAGR during the forecast period. The expanding health care sector and increasing FDI in the region are driving the market growth. The growing awareness of early and accurate diagnosis increases product demand, and the increased geriatric population is driving the market growth in the region.
In-Vitro Diagnostics (IVD) Quality Control Market: Share & Competitor Analysis
Some of the key players operating in the in-vitro diagnostics (IVD) quality control market include: Abbott Laboratories, Inc., Siemens Healthcare GmbH, Roche Diagnostics, Bio-Techne; Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company (BD), bioMerieux, Inc., Quidel Corp., Alere, Inc., Sysmex Corp., Sero AS, Thermo Fisher Scientific, Inc., Danaher Corporation, Sun Diagnostics, LLC, and Ortho Clinical Diagnostics, Inc., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In December 2019, Technopath Clinical Diagnostics entered into partnership with Data Innovations LLC to offer a robust portfolio of quality control data management solutions to their customers
In October 2019, Thermo Fisher Scientific launched its new panel i.e. Acrometrix BCR-ABL Panel, a new external molecular quality control panel for the analytical validation of BCR-ABL test methods
Related Report: Global Hematology Analyzers and Reagents Market Size, Trends & Analysis - Forecasts to 2026
Check the Press Release on Global In-vitro Diagnostics (IVD) Quality Control Market Report
In-vitro Diagnostics (IVD) Quality Control Market: By Type
In-vitro diagnostics (IVD) quality control Market: By End-Use
In-Vitro Diagnostics (IVD) Quality Control Market: By Application
In-Vitro Diagnostics (IVD) Quality Control Market: By Region
The global In-vitro Diagnostics (IVD) Quality Control Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the In-vitro Diagnostics (IVD) Quality Control Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
A dedicated client engagement team for round the clock support in terms of requirement gathering, query handling, and any other support activity.
More than 50% of innovation comes from the voice of the customer through which our analysts find blindspots in your revenue decisions.
The best vision is actionable insights across high growth markets with GMEs disruptive research methodology.
Disruptive research that correlates markets, technologies, new use cases and companies.
80% of Fortune 2000 use GME for their growth strategies.
Get in-depth analysis of the COVID-19 impact on this study
Benchmarking the rapid strategy shifts of the Top 100 companies in this market space
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
